创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the features of the iHuPBMC-NK platform?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-25 10:24
  • Views:

(Summary description)Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research

InnoModels Biotechnology: What are the features of the iHuPBMC-NK platform?

(Summary description)Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-25 10:24
  • Views:
Information

Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research.
1、Highly simulates the human environment
The iHuPBMC-NK platform adopts a humanized peripheral blood single nucleated cell (PBMC) system, which contains not only NK cells, but also a rich variety of other immune cell types, which greatly improves the physiological relevance and accuracy of the experiments. By simulating the complex microenvironment in the human body, the platform can more realistically reflect the behavior and function of NK cells in vivo.
2. Precise regulation of NK cell activity
The platform has the ability to precisely regulate the activity of NK cells. Researchers can regulate the proliferation, differentiation and activation process of NK cells according to experimental needs, so as to deeply explore the mechanism of NK cells in different physiological and pathological conditions.
3、Promote the development of NK cell therapy
With the rise of immunotherapy, NK cell therapy shows great potential in the fields of cancer, viral infection, etc. The iHuPBMC-NK platform provides strong support for the research of NK cell therapy. Through this platform, researchers can assess the impact of different treatment strategies on NK cell function, optimize treatment plans, and promote NK cell therapy from laboratory to clinical application.

 


4. Powerful data analysis and processing capabilities
The platform is equipped with an advanced data analysis and processing system, which enables comprehensive and in-depth analysis of multiple biological features of NK cells. Through high-throughput sequencing, single-cell sequencing and other technical means, researchers can obtain key information on gene expression, protein interactions, etc. of NK cells, which provides strong support for revealing the complexity of NK cell functions.
5. Easy to operate and reproducible
The iHuPBMC-NK platform is designed to focus on user-friendliness and reproducibility, with easy and fast experimental operation and stable and reliable results. This helps researchers to carry out NK cell-related research quickly and efficiently in busy laboratory work.
In summary, the iHuPBMC-NK platform of InnoModels Biotechnology has become a powerful assistant in the field of NK cell research with its highly simulated human environment, precise regulation of NK cell activity, promotion of NK cell therapy, powerful data analysis and processing capabilities, as well as ease of operation and reproducibility. With the continuous revelation of NK cell function and the advancement of immunotherapy technology, the platform is expected to play an even more important role in the future and make significant contributions to human health.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司